USPTO serial 79375030
CONTERA PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 5, 2024
- Examiner
- HUDSON, TAMARA BREE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CONTERA PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julie A. Greenberg
Julie A. Greenberg Reising Ethington P.C.755 W Big Beaver Rd, Suite 1850Troy, MI 48084United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Antibiotics; antivirals, chemical preparations for pharmaceutical purposes, namely, for treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; drugs for medical purposes, namely, pharmaceutical preparations for the treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; medicines for human purposes for treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; pharmaceutical preparations for the treatment, prevention or alleviation of diseases of the central nervous system, neurological disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's Disease, dyskinesias and complications arising from same; vitamin preparations; health supplements for medical use, namely, health food supplements, dietary and nutritional supplements, and herbal supplements | ACTIVE | — |
| 035 | Pharmaceutical sales promotion for others; business information on pharmaceuticals; business management assistance on pharmaceuticals; analysis of market search data; market research studies; advertising services; arranging of pharmaceutical sale, namely, procuring of contracts for others for the purchase and sale of pharmaceuticals; export-import agency services; sales agency business of health supplementary food, namely, marketing services for health supplementary foods, promotional marketing and representation services for sales to the public sector of health supplementary food, independent sales representatives in the field of health supplementary food; retail store services in the field of cosmetics; retail store services in the field of dentifrices; retail store services in the field of toothbrushes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Contera Pharma A/S
- Other trademarks owned by Contera Pharma ApS
- Other trademarks owned by Contera Pharma ApS
- Other trademarks owned by Contera Pharma ApS
- Other trademarks in Class 005
- Other trademarks in Class 035
- Similar marks named CONTERA PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 6, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 6, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 6, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 2, 2025 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 22, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 26, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 8, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 8, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 5, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 10, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 22, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 19, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 19, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 29, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 29, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 8, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 7, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 11, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 7, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 21, 2023 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |